Although it is clear that amphetamine-induced dopamine (DA) release mediated by the dopamine transporter (DAT) is integral to the behavioral actions of this psychostimulant, the mechanism of this release is not clear. In this study, we explored the requirement for intracellular Ca 2ϩ in amphetamine-induced DA efflux and currents mediated by the human DAT. The patchclamp technique in the whole-cell configuration was used on Na ϩ and DA-preloaded human embryonic kidney 293 cells stably transfected with the human DAT (hDAT cells). Chelation of intracellular Ca 2ϩ by inclusion of 50 M BAPTA in the wholecell pipette reduced the voltage-dependent amphetamine-induced hDAT current, with the greatest effect seen at positive voltages. Likewise, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) reduced amphetamine-induced DA efflux as measured by amperometry. Furthermore, preincubation of the cells with 50 M BAPTA acetoxy methyl ester (AM) or thapsigargin also blocked amphetamine-induced release of preloaded N-methyl-4-[ 3 H]phenylpyridinium from superfused hDAT cells. BAPTA-AM also reduced DA release from striatal synaptosomes. Amphetamine also led to an increase in intracellular Ca 2ϩ that was blocked by prior treatment with 5 M thapsigargin or 10 M cocaine. These studies demonstrate that amphetamine-induced DAT-mediated currents and substrate efflux require internal Ca 2ϩ and that amphetamine can stimulate dopamine efflux by regulating cytoplasmic Ca 2ϩ levels through its interaction with DAT.The plasmalemmal dopamine transporter, DAT, is essential for regulation of synaptic levels of dopamine (DA). Although the primary physiological function of DAT is to clear DA from the synapse through reuptake, DAT can also mediate DA efflux. As hypothesized for other gated carriers, the function of DAT seems to depend on conformational changes that alternately expose extracellular and intracellular substrate binding sites (Rudnick and Clark, 1993;Abramson et al., 2003). Thus, after transport and dissociation of substrate, the "inward-facing" conformation of DAT is able to bind cytoplasmic DA and carry it to the outside. DA efflux is most apparent in response to a substrate such as amphetamine (AMPH). Because the locomotor and reinforcing effects of AMPH are a result of its ability to release DA into the synapse (Seiden et al., 1993;Giros et al., 1996;Koob and Nestler, 1997), AMPH-induced DA efflux has been highly investigated. AMPH increases the prevalence of the inwardfacing conformation of the plasmalemmal catecholamine transporter (Langeloh et al., 1987), inhibits monoamine oxidase activity, blocks the vesicular transporter (VMAT2), and disrupts the vesicular proton gradient, making more cytoplasmic DA available to the inward-facing DAT (Seiden et al., 1993;Sulzer et al., 1995). Emerging evidence, however, indicates that AMPH-mediated DA efflux does not rely exclusively on the ability of AMPH to increase the availability of inward